BLUEROCK RESIDENTIAL GROWTH REIT INC 8.250% SR A CUMULATIVE REDEEMABLE PFD STK
BRG.PRA
BRG.PRA was delisted on the 25th of February, 2021.
1 hedge funds and large institutions have $8K invested in BLUEROCK RESIDENTIAL GROWTH REIT INC 8.250% SR A CUMULATIVE REDEEMABLE PFD STK in 2019 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
67% less funds holding
Funds holding: 3 → 1 (-2)
100% less capital invested
Capital invested by funds: $3.63M → $8K (-$3.62M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KIA
KCM Investment Advisors
Greenbrae,
California
|
-$3.5M |
| 2 |
BEAM
Baker Ellis Asset Management
Vancouver,
Washington
|
-$121K |
BRG.PRA Hedge Fund Activity: Q1 2019 in Review
1 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in BLUEROCK RESIDENTIAL GROWTH REIT INC 8.250% SR A CUMULATIVE REDEEMABLE PFD STK (BRG.PRA) for Q1 2019, worth a combined $8K — down 100% from $3.63M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BRG.PRA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was KCM Investment Advisors, exiting entirely with an estimated $3.5M sold.
- 1 institutional investor held BLUEROCK RESIDENTIAL GROWTH REIT INC 8.250% SR A CUMULATIVE REDEEMABLE PFD STK (BRG.PRA) as of Q1 2019, down from 3 in Q4 2018.
- Funds reported $8K of BLUEROCK RESIDENTIAL GROWTH REIT INC 8.250% SR A CUMULATIVE REDEEMABLE PFD STK stock for Q1 2019, down 100% quarter-over-quarter.
- 0 funds opened new BLUEROCK RESIDENTIAL GROWTH REIT INC 8.250% SR A CUMULATIVE REDEEMABLE PFD STK positions in Q1 2019 and 2 closed out, a net change of -2 holders.
- The largest BLUEROCK RESIDENTIAL GROWTH REIT INC 8.250% SR A CUMULATIVE REDEEMABLE PFD STK seller in Q1 2019 was KCM Investment Advisors, an estimated $3.5M sold.
Based on aggregated 13F filings for Q1 2019.